1. Home
  2. VYGR vs ONTF Comparison

VYGR vs ONTF Comparison

Compare VYGR & ONTF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VYGR
  • ONTF
  • Stock Information
  • Founded
  • VYGR 2013
  • ONTF 1998
  • Country
  • VYGR United States
  • ONTF United States
  • Employees
  • VYGR N/A
  • ONTF N/A
  • Industry
  • VYGR Biotechnology: Pharmaceutical Preparations
  • ONTF Computer Software: Prepackaged Software
  • Sector
  • VYGR Health Care
  • ONTF Technology
  • Exchange
  • VYGR Nasdaq
  • ONTF Nasdaq
  • Market Cap
  • VYGR 165.5M
  • ONTF 231.9M
  • IPO Year
  • VYGR 2015
  • ONTF 2021
  • Fundamental
  • Price
  • VYGR $2.74
  • ONTF $5.69
  • Analyst Decision
  • VYGR Strong Buy
  • ONTF Hold
  • Analyst Count
  • VYGR 8
  • ONTF 4
  • Target Price
  • VYGR $14.33
  • ONTF $5.33
  • AVG Volume (30 Days)
  • VYGR 377.3K
  • ONTF 156.2K
  • Earning Date
  • VYGR 05-06-2025
  • ONTF 05-07-2025
  • Dividend Yield
  • VYGR N/A
  • ONTF N/A
  • EPS Growth
  • VYGR N/A
  • ONTF N/A
  • EPS
  • VYGR N/A
  • ONTF N/A
  • Revenue
  • VYGR $66,958,000.00
  • ONTF $145,087,000.00
  • Revenue This Year
  • VYGR N/A
  • ONTF N/A
  • Revenue Next Year
  • VYGR $45.34
  • ONTF N/A
  • P/E Ratio
  • VYGR N/A
  • ONTF N/A
  • Revenue Growth
  • VYGR N/A
  • ONTF N/A
  • 52 Week Low
  • VYGR $2.65
  • ONTF $4.35
  • 52 Week High
  • VYGR $9.55
  • ONTF $7.04
  • Technical
  • Relative Strength Index (RSI)
  • VYGR 33.88
  • ONTF 66.42
  • Support Level
  • VYGR $2.71
  • ONTF $5.26
  • Resistance Level
  • VYGR $2.99
  • ONTF $5.60
  • Average True Range (ATR)
  • VYGR 0.18
  • ONTF 0.19
  • MACD
  • VYGR -0.05
  • ONTF 0.05
  • Stochastic Oscillator
  • VYGR 10.86
  • ONTF 95.36

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

About ONTF ON24 Inc.

ON24 Inc provides a cloud-based intelligent engagement platform that combines experiences with personalization and content, to enable sales and marketing organizations to capture and act on connected insights at scale. The Company's platform offers a portfolio of interactive and hyper-personalized digital experience products that create and capture actionable, real-time data at scale from millions of professionals to provide businesses with buying signals and behavioral insights to efficiently convert prospects into customers. It provides solutions to Financial services, Life Sciences, Life sciences, Insurance, Technology, Associations, and Others.

Share on Social Networks: